OBJECTIVES: The purpose of this study was to describe the phenotypic characteristics of an inherited myxomatous valvular dystrophy mapped to Xq28. BACKGROUND: Myxomatous valve dystrophies are a frequent cause of valvular diseases, the most common being idiopathic mitral valve prolapse. They form a group of heterogeneous diseases difficult to subclassify. The first mapping of the gene for a myxoid valvular dystrophy to Xq28 allowed investigation of the phenotype of affected members in a large family and characterization of the disease. METHODS: Among the 318 members in the pedigree, 89 agreed to participate in this study. Phenotypic characteristics were investigated using clinical examination, transthoracic echocardiography and biological analysis (F.VIII activity). Genetic status was based on haplotype analysis. RESULTS: Among 46 males, 9 were hemizygous to the mutant allele and had an obvious mitral and/or aortic myxomatous valve defect, and 4 had undergone valvular surgery. All had typical mitral valve prolapse associated in six cases with moderate to severe aortic regurgitation. The valve defect cosegregated with mild hemophilia A (F.VIII activity = 0.32 +/- 0.05). The 37 remaining males had normal valves and normal F.VIII activity. Heterozygous women were identified on the basis of their haplotypes. Among the 17 women heterozygous to the mutant allele, moderate mitral regurgitation was present in 8, associated with mild mitral valve prolapse in 1 and aortic regurgitation in 3, whereas 2 women had isolated mild aortic regurgitant murmur. In heterozygotes, the penetrance value was 0.60 but increased with age. CONCLUSION: X-linked myxomatous valvular disease is characterized by mitral valve dystrophy frequently associated with degeneration of the aortic valves affecting males and, to a lower severity, females. The first localization of a gene for myxomatous valvular diseases is the first step for the subclassification of these diseases.
OBJECTIVES: The purpose of this study was to describe the phenotypic characteristics of an inherited myxomatous valvular dystrophy mapped to Xq28. BACKGROUND:Myxomatous valve dystrophies are a frequent cause of valvular diseases, the most common being idiopathic mitral valve prolapse. They form a group of heterogeneous diseases difficult to subclassify. The first mapping of the gene for a myxoid valvular dystrophy to Xq28 allowed investigation of the phenotype of affected members in a large family and characterization of the disease. METHODS: Among the 318 members in the pedigree, 89 agreed to participate in this study. Phenotypic characteristics were investigated using clinical examination, transthoracic echocardiography and biological analysis (F.VIII activity). Genetic status was based on haplotype analysis. RESULTS: Among 46 males, 9 were hemizygous to the mutant allele and had an obvious mitral and/or aortic myxomatous valve defect, and 4 had undergone valvular surgery. All had typical mitral valve prolapse associated in six cases with moderate to severe aortic regurgitation. The valve defect cosegregated with mild hemophilia A (F.VIII activity = 0.32 +/- 0.05). The 37 remaining males had normal valves and normal F.VIII activity. Heterozygous women were identified on the basis of their haplotypes. Among the 17 women heterozygous to the mutant allele, moderate mitral regurgitation was present in 8, associated with mild mitral valve prolapse in 1 and aortic regurgitation in 3, whereas 2 women had isolated mild aortic regurgitant murmur. In heterozygotes, the penetrance value was 0.60 but increased with age. CONCLUSION:X-linked myxomatous valvular disease is characterized by mitral valve dystrophy frequently associated with degeneration of the aortic valves affecting males and, to a lower severity, females. The first localization of a gene for myxomatous valvular diseases is the first step for the subclassification of these diseases.
Authors: Lisa J Martin; Vijaya Ramachandran; Linda H Cripe; Robert B Hinton; Gregor Andelfinger; Meredith Tabangin; Kerry Shooner; Mehdi Keddache; D Woodrow Benson Journal: Hum Genet Date: 2007-01-04 Impact factor: 4.132
Authors: Jean-François Avierinos; Jocelyn Inamo; Francesco Grigioni; Bernard Gersh; Clarence Shub; Maurice Enriquez-Sarano Journal: Ann Intern Med Date: 2008-12-02 Impact factor: 25.391
Authors: Thierry Le Tourneau; Jean Mérot; Antoine Rimbert; Solena Le Scouarnec; Vincent Probst; Hervé Le Marec; Robert A Levine; Jean-Jacques Schott Journal: Heart Date: 2018-01-19 Impact factor: 5.994
Authors: Aurélie Lardeux; Florence Kyndt; Simon Lecointe; Hervé Le Marec; Jean Merot; Jean-Jacques Schott; Thierry Le Tourneau; Vincent Probst Journal: J Cardiovasc Transl Res Date: 2011-07-20 Impact factor: 4.132
Authors: Vishal Gupta; Janet E Barzilla; Joe S Mendez; Elizabeth H Stephens; Elaine L Lee; C David Collard; Rodolfo Laucirica; Paul H Weigel; Kathryn J Grande-Allen Journal: Cardiovasc Pathol Date: 2008-07-14 Impact factor: 2.185
Authors: Thierry Le Tourneau; Solena Le Scouarnec; Caroline Cueff; Daniel Bernstein; Jan J J Aalberts; Simon Lecointe; Jean Mérot; Jonathan A Bernstein; Toon Oomen; Christian Dina; Matilde Karakachoff; Hubert Desal; Ousama Al Habash; Francesca N Delling; Romain Capoulade; Albert J H Suurmeijer; David Milan; Russell A Norris; Roger Markwald; Elena Aikawa; Susan A Slaugenhaupt; Xavier Jeunemaitre; Albert Hagège; Jean-Christian Roussel; Jean-Noël Trochu; Robert A Levine; Florence Kyndt; Vincent Probst; Hervé Le Marec; Jean-Jacques Schott Journal: Eur Heart J Date: 2018-04-14 Impact factor: 35.855
Authors: Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris Journal: J Am Heart Assoc Date: 2021-06-22 Impact factor: 5.501